These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evidence for a functional role of endothelial transient receptor potential V4 in shear stress-induced vasodilatation. Köhler R; Heyken WT; Heinau P; Schubert R; Si H; Kacik M; Busch C; Grgic I; Maier T; Hoyer J Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1495-502. PubMed ID: 16675722 [TBL] [Abstract][Full Text] [Related]
7. Functional transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 channels along different segments of the renal vasculature. Chen L; Kaßmann M; Sendeski M; Tsvetkov D; Marko L; Michalick L; Riehle M; Liedtke WB; Kuebler WM; Harteneck C; Tepel M; Patzak A; Gollasch M Acta Physiol (Oxf); 2015 Feb; 213(2):481-91. PubMed ID: 25069877 [TBL] [Abstract][Full Text] [Related]
8. Modulation of the TRPV4 ion channel as a therapeutic target for disease. Grace MS; Bonvini SJ; Belvisi MG; McIntyre P Pharmacol Ther; 2017 Sep; 177():9-22. PubMed ID: 28202366 [TBL] [Abstract][Full Text] [Related]
9. Role of cytochrome P450-dependent transient receptor potential V4 activation in flow-induced vasodilatation. Loot AE; Popp R; Fisslthaler B; Vriens J; Nilius B; Fleming I Cardiovasc Res; 2008 Dec; 80(3):445-52. PubMed ID: 18682435 [TBL] [Abstract][Full Text] [Related]
10. Renoprotection: focus on TRPV1, TRPV4, TRPC6 and TRPM2. Markó L; Mannaa M; Haschler TN; Krämer S; Gollasch M Acta Physiol (Oxf); 2017 Mar; 219(3):589-612. PubMed ID: 28028935 [TBL] [Abstract][Full Text] [Related]
11. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Watanabe H; Vriens J; Prenen J; Droogmans G; Voets T; Nilius B Nature; 2003 Jul; 424(6947):434-8. PubMed ID: 12879072 [TBL] [Abstract][Full Text] [Related]
13. Glycosylation of the osmoresponsive transient receptor potential channel TRPV4 on Asn-651 influences membrane trafficking. Xu H; Fu Y; Tian W; Cohen DM Am J Physiol Renal Physiol; 2006 May; 290(5):F1103-9. PubMed ID: 16368742 [TBL] [Abstract][Full Text] [Related]
14. TRPV4 agonists and antagonists. Vincent F; Duncton MA Curr Top Med Chem; 2011; 11(17):2216-26. PubMed ID: 21671873 [TBL] [Abstract][Full Text] [Related]
15. Transient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney. Kassmann M; Harteneck C; Zhu Z; Nürnberg B; Tepel M; Gollasch M Acta Physiol (Oxf); 2013 Mar; 207(3):546-64. PubMed ID: 23253200 [TBL] [Abstract][Full Text] [Related]
16. P2Y1 Receptor Activation of the TRPV4 Ion Channel Enhances Purinergic Signaling in Satellite Glial Cells. Rajasekhar P; Poole DP; Liedtke W; Bunnett NW; Veldhuis NA J Biol Chem; 2015 Nov; 290(48):29051-62. PubMed ID: 26475857 [TBL] [Abstract][Full Text] [Related]
18. Recent advances on the structure and the function relationships of the TRPV4 ion channel. Sánchez-Hernández R; Benítez-Angeles M; Hernández-Vega AM; Rosenbaum T Channels (Austin); 2024 Dec; 18(1):2313323. PubMed ID: 38354101 [TBL] [Abstract][Full Text] [Related]
19. Heat-evoked activation of the ion channel, TRPV4. Güler AD; Lee H; Iida T; Shimizu I; Tominaga M; Caterina M J Neurosci; 2002 Aug; 22(15):6408-14. PubMed ID: 12151520 [TBL] [Abstract][Full Text] [Related]